Stocks · News reference
Cantor Fitzgerald Reiterates Overweight on Core Scientific, Maintains $39 Price Target
Cantor Fitzgerald analyst Brett Knoblauch reiterates Core Scientific (NASDAQ:CORZ) with a Overweight and maintains $39 price target.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Cantor Fitzgerald Maintains Overweight on Core Scientific, Lowers Price Target to $30
Cantor Fitzgerald analyst Brett Knoblauch maintains Core Scientific (NASDAQ:CORZ) with a Overweight and lowers the price target from $39 to $30.
Stock Market Today, Oct. 15: Iren Stock Recovers, but Still Slides on Concerns Over Neocloud Provider Viability
Iren (IREN) closed down 0.56% at $30.39 after initially plunging below $27 following Gartner's warning that over 80% of neocloud providers could cease independent operations by 2030 and $3.5 trillion in AI infrastructure investments could be at risk. The stock recovered somewhat as investors recognized Iren has about half its GPU capex funded through customer prepayments, suggesting company-specific resilience versus sector-wide concerns.
BTIG Reiterates Buy on Core Scientific, Maintains $38 Price Target
BTIG analyst Gregory Lewis reiterates Core Scientific (NASDAQ:CORZ) with a Buy and maintains $38 price target.